Lichen China Faces Nasdaq Delisting Warning
Ticker: LICN · Form: 6-K · Filed: Jan 27, 2025 · CIK: 1876766
| Field | Detail |
|---|---|
| Company | Lichen China LTD (LICN) |
| Form Type | 6-K |
| Filed Date | Jan 27, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | bearish |
Sentiment: bearish
Topics: compliance, delisting-risk, nasdaq
TL;DR
Nasdaq says Lichen China's stock price is too low, risking delisting.
AI Summary
Lichen China Limited received a notification from Nasdaq on January 23, 2025, stating it is not in compliance with the minimum bid price requirement. The company is required to maintain a minimum bid price of $1.00 per share to remain listed on the Nasdaq Capital Market.
Why It Matters
Failure to regain compliance with Nasdaq's minimum bid price rule could lead to the delisting of Lichen China Limited's shares, significantly impacting liquidity and investor confidence.
Risk Assessment
Risk Level: medium — The company is at risk of delisting from Nasdaq if it cannot meet the minimum bid price requirement, which could negatively impact its stock value and investor confidence.
Key Numbers
- $1.00 — Minimum Bid Price (The minimum price per share required by Nasdaq for continued listing on the Nasdaq Capital Market.)
Key Players & Entities
- Lichen China Limited (company) — The company receiving the Nasdaq notification.
- Nasdaq (company) — The stock exchange that issued the non-compliance notice.
- January 23, 2025 (date) — The date Lichen China Limited received the notification from Nasdaq.
- $1.00 (dollar_amount) — The minimum bid price required by Nasdaq for continued listing.
FAQ
What specific Nasdaq rule is Lichen China Limited currently not in compliance with?
Lichen China Limited is not in compliance with the minimum bid price requirement, which mandates a bid price of at least $1.00 per share.
When did Lichen China Limited receive the notification from Nasdaq?
The company received the notification on January 23, 2025.
What is the consequence of not meeting the minimum bid price requirement?
Failure to meet the minimum bid price requirement could lead to the delisting of the company's securities from the Nasdaq Capital Market.
What is the address of Lichen China Limited's principal executive office?
The address is 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013.
Does Lichen China Limited file annual reports under Form 20-F or Form 40-F?
Lichen China Limited files annual reports under cover of Form 20-F.
Filing Stats: 607 words · 2 min read · ~2 pages · Grade level 14.5 · Accepted 2025-01-27 16:10:23
Key Financial Figures
- $1.00 — maintain a minimum closing bid price of $1.00 per share (the “Minimum Bid Price
Filing Documents
- ea0228791-6k_lichen.htm (6-K) — 14KB
- ea022879101ex99-1_lichen.htm (EX-99.1) — 8KB
- 0001213900-25-006994.txt ( ) — 22KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month ended January 2025 Commission File No. 001-41493 LICHEN CHINA LIMITED (Translation of registrant’s name into English) 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F Form 40-F Nasdaq Continued Compliance On January 23, 2025 (the “Notification Date”), Lichen China Limited (the “Company”) received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the Company’s Class A ordinary shares (“Shares”) was below $1.00 per share for 30 consecutive business days. The notification does not impact the listing of the Company’s Shares on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days from the Notification Date, until July 22, 2025, to regain compliance with the Minimum Bid Price Requirement. During this period, the Company’s Shares will continue to trade on the Nasdaq Capital Market. If at any time before July 22, 2025, the bid price of the Company’s Shares closes at or above $1.00 per share for a minimum of 10 consecutive trading days, Nasdaq will provide written notification that the Company has achieved compliance with this Minimum Bid Price Requirement. In the event the Company does not regain compliance by July 22, 2025, the Company may be eligible for an additional 180 calendar day compliance period to demonstrate compliance with the bid price requirement. To qualify for the additional 180-day period, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice to Nasdaq of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If the Company does not qualify for the second compliance period or fails to regain compliance during the second 180-day period, then Nasdaq will notify the Company of its determination to delist the Company. The Company intends to take all reasonable measures to regain compliance under the Nasdaq Listing Rule 5550(a)(2). However, there can be no assurance that the Company will be able to maintain compliance with the Nasdaq Capital Market’s continued listing requirements or regain compliance with the Minimum Bid Price Requirement. This information is being provided solely to comply with Nasdaq Listing Rules requiring public announcement of the Company’s receipt of the letter from Nasdaq. On January 27, 2025, the Company issued a press release announcing that the non-compliance with the Nasdaq listing requirement. The full text of the press release is attached to this current report on Form 6-K as Exhibit 99.1. EXHIBIT INDEX Exhibit No. Description 99.1 Press Release, dated January 27, 2025 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Lichen China Limited Date: January 27, 2025 By: /s/ Ya Li Name: Ya Li Title Chief Executive Officer 2